Bisphosphonates in bone diseases

@article{Sparidans1998BisphosphonatesIB,
  title={Bisphosphonates in bone diseases},
  author={Rolf W. Sparidans and Irene M. Twiss and Stephanie Talbot},
  journal={Pharmacy World and Science},
  year={1998},
  volume={20},
  pages={206-213}
}
Bisphosphonates are a class of drugs which are strongly attracted to the bone where they influence the calcium metabolism, mainly by inhibition of the osteoclast-mediated bone resorption. This property makes these compounds suited for the treatment of several diseases of the bone. In Paget's disease, several bisphosphonates can reduce bone pain and decrease the bone turnover 60‐70%. Cyclical oral etidronate and daily oral alendronate both proved to reduce the vertebral fracture rate for… CONTINUE READING
15 Citations
112 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 112 references

Guidelines for the treatment of hypercalcemia associated with malignancy

  • L. Nakashima
  • J Oncol Pharm Practice
  • 1997

Bisfosfonaten bij osteoporose; een herbeoordeling

  • SE Papapoulos, Lockefeer JHM
  • Ned Tijdschr Geneeskd
  • 1996

Similar Papers

Loading similar papers…